Literature DB >> 15019925

Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?

Keita Wada1, Tadahiro Takada, Hideki Yasuda, Hodaka Amano, Masahiro Yoshida, Maki Sugimoto, Hiroshi Irie.   

Abstract

Intraductal papillary mucinous tumors of the pancreas show a unique histologic feature in that the wide spectrum of intraductal epithelium is observed in the same pancreas. The aim of this study was to clarify whether or not the "clonal progression" relates to the development of this tumor. A total of 210 intraductal epithelium samples were microdissected from 23 resected specimens of intraductal papillary mucinous tumors of the pancreas, including nine carcinomas, five borderline tumors, and nine adenomas. After histologic grading (grades 1 to 4) of the individual epithelium, the K-ras point mutation and loss of heterozygosity in 9p21(p16) and 17p13(p53) were investigated. From the distribution of the K-ras point mutation of 210 microdissected specimens, an identical sequence of K-ras was demonstrated in the precursor lesions in most cases. K-ras mutation showed a single pattern, and the multiple or heterogeneous mutation pattern was not seen in this study. In the same ways, the distribution of loss of heterozygosity in 9p21(p16) and 17p13(p53) of 210 microdissected specimens was shown to be mostly clonal, without the presence of the genetic alterations. Such distributions of the identical genetic statuses in the precursor lesions are consistent with the presence of clonal progression during the development of this tumor.

Entities:  

Mesh:

Year:  2004        PMID: 15019925     DOI: 10.1016/j.gassur.2003.09.027

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

1.  Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients.

Authors:  F Rickaert; M Cremer; J Devière; L Tavares; J P Lambilliotte; S Schröder; D Wurbs; G Klöppel
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

2.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Authors:  C A Moskaluk; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.

Authors:  T Izawa; T Obara; S Tanno; Y Mizukami; N Yanagawa; Y Kohgo
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

4.  K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas.

Authors:  K Satoh; T Shimosegawa; S Moriizumi; M Koizumi; T Toyota
Journal:  Pancreas       Date:  1996-05       Impact factor: 3.327

5.  Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.

Authors:  H Inoue; T Furukawa; M Sunamura; K Takeda; S Matsuno; A Horii
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

6.  Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.

Authors:  K Z'graggen; J A Rivera; C C Compton; M Pins; J Werner; C Fernández-del Castillo; D W Rattner; K B Lewandrowski; A K Rustgi; A L Warshaw
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

7.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

8.  Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.

Authors:  Koji Yoshizawa; Hideo Nagai; Shinji Sakurai; Mitsugu Hironaka; Shojiroh Morinaga; Ken Saitoh; Masashi Fukayama
Journal:  Virchows Arch       Date:  2002-10-12       Impact factor: 4.064

9.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Intraductal mucin-producing tumors of the pancreas.

Authors:  Y Kawarada; T Yano; T Yamamoto; H Yokoi; T Imai; Y Ogura; R Mizumoto
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

View more
  12 in total

1.  High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).

Authors:  Nir Lubezky; Menahem Ben-Haim; Sylvia Marmor; Eli Brazowsky; Gideon Rechavi; Joseph M Klausner; Yoram Cohen
Journal:  J Gastrointest Surg       Date:  2011-01-12       Impact factor: 3.452

2.  Natural history of intraductal papillary mucinous neoplasia: How much do we really know?

Authors:  Chad G Ball; Thomas J Howard
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 3.  Cystic neoplasms of the pancreas.

Authors:  Hop S Tran Cao; Benjamin Kellogg; Andrew M Lowy; Michael Bouvet
Journal:  Surg Oncol Clin N Am       Date:  2010-04       Impact factor: 3.495

4.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

5.  Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.

Authors:  Sahar Nissim; Gregory E Idos; Bechien Wu
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

Review 6.  Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.

Authors:  Claudio Bassi; Michael G Sarr; Keith D Lillemoe; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2007-12-19       Impact factor: 3.452

7.  Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma.

Authors:  Stefan Fritz; Carlos Fernandez-del Castillo; Mari Mino-Kenudson; Stefano Crippa; Vikram Deshpande; Gregory Y Lauwers; Andrew L Warshaw; Sarah P Thayer; A John Iafrate
Journal:  Ann Surg       Date:  2009-03       Impact factor: 12.969

8.  Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Dario Garcia-Carracedo; Andrew T Turk; Stuart A Fine; Nathan Akhavan; Benjamin C Tweel; Ramon Parsons; John A Chabot; John D Allendorf; Jeanine M Genkinger; Helen E Remotti; Gloria H Su
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

9.  Role of emerging molecular markers in pancreatic cyst fluid.

Authors:  Mohammad Al-Haddad
Journal:  Endosc Ultrasound       Date:  2015 Oct-Dec       Impact factor: 5.628

Review 10.  Focus on the intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Fernando Gallucci; Assunta Langellotto; Rosaria De Ritis; Generoso Uomo
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.